Pages with the fewest revisions
Jump to navigation
Jump to search
Showing below up to 50 results in range #10,881 to #10,930.
- Nephrotic syndrome MRI (1 revision)
- Nephrotic syndrome and risk of venous and arterial thromboembolism (1 revision)
- Nephrotome (1 revision)
- Nerelimomab (1 revision)
- Nerisopam (1 revision)
- Nerol (1 revision)
- Neroli (1 revision)
- Nerve (1 revision)
- Nerve conduction study (1 revision)
- Nerve growth factor IB (1 revision)
- Nerve injury (1 revision)
- Nerve of pterygoid canal (1 revision)
- Nerve root (1 revision)
- Nerve to the stapedius (1 revision)
- Nerve to the subclavius (1 revision)
- Nervous system (1 revision)
- Nervous system disease (1 revision)
- Nervous tissue (1 revision)
- Nervus intermedius (1 revision)
- Net clinical benefit (1 revision)
- Netherlands Forensic Institute (1 revision)
- Netherton's syndrome (1 revision)
- Netrin G1 (1 revision)
- Netrin G2 (1 revision)
- Nettle (1 revision)
- Neural Fibrolipoma (1 revision)
- Neural backpropagation (1 revision)
- Neural crest (1 revision)
- Neural development (1 revision)
- Neural development in humans (1 revision)
- Neuralgia CT (1 revision)
- Neuralgia MRI (1 revision)
- Neuralgia case study one (1 revision)
- Neuralgia classification (1 revision)
- Neuralgia cost-effectiveness of therapy (1 revision)
- Neuralgia differential diagnosis (1 revision)
- Neuralgia future or investigational therapies (1 revision)
- Neuralgia historical perspective (1 revision)
- Neuralgia history and symptoms (1 revision)
- Neuralgia other imaging findings (1 revision)
- Neuralgia pathophysiology (1 revision)
- Neuralgia physical examination (1 revision)
- Neuralgia primary prevention (1 revision)
- Neuralgia screening (1 revision)
- Neuralgia secondary prevention (1 revision)
- Neuralized e3 ubiquitin protein ligase 3 (1 revision)
- Neurally mediated syncope (1 revision)
- Neuraminic acid (1 revision)
- Neuraminidase inhibitor (1 revision)
- Neuraxial blockade (1 revision)